Features of indeterminate results of QuantiFERON-TB Gold In-Tube test in patients with haematological malignancies

1. World Health Organization . WHO guidelines on tuberculosis infection prevention and control, https://www.who.int/tb/publications/2019/guidelines-tuberculosis-infection-prevention-2019/en/ (2019, accessed 1 July 2020).
Google Scholar2. Zumla, A, Raviglione, M, Hafner, R, et al. Tuberculosis. N Engl J Med 2013; 368: 745–755.
Google Scholar | Crossref | Medline3. Getahun, H, Matteelli, A, Abubakar, I, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 2015; 46: 1563–1576.
Google Scholar | Crossref | Medline4. Getahun, H, Gunneberg, C, Granich, R, et al. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 2010; 50(Suppl. 3): S201–S207.
Google Scholar | Crossref | Medline5. Baronnet, L, Barnetche, T, Kahn, V, et al. Incidence of tuberculosis in patients with rheumatoid arthritis: a systematic literature review. Joint Bone Spine 2011; 78: 279–284.
Google Scholar | Crossref | Medline6. Aberra, FN, Stettler, N, Brensinger, C, et al. Risk for active tuberculosis in inflammatory bowel disease patients. Clin Gastroenterol Hepatol 2007; 5: 1070–1075.
Google Scholar | Crossref | Medline7. Dobler, CC, McDonald, SP, Marks, GB. Risk of tuberculosis in dialysis patients: a nationwide cohort study. PLoS One 2011; 6: e29563.
Google Scholar | Crossref | Medline8. Kamboj, M, Sepkowitz, KA. The risk of tuberculosis in patients with cancer. Clin Infect Dis 2006; 42: 1592–1595.
Google Scholar | Crossref | Medline9. Dobler, CC . Biological agents and tuberculosis: risk estimates and screening strategies. Int J Rheum Dis 2015; 18: 264–267.
Google Scholar | Crossref | Medline10. Dobler, CC . Biologic agents and tuberculosis. Microbiol Spectr 2016; 4.
Google Scholar | Crossref | Medline11. Munoz, P, Rodriguez, C, Bouza, E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005; 40: 581–587.
Google Scholar | Crossref | Medline12. Redelman-Sidi, G, Sepkowitz, KA. IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults. Am J Respir Crit Care Med 2013; 188: 422–431.
Google Scholar | Crossref | Medline | ISI13. Pai, M, Denkinger, CM, Kik, SV, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev 2014; 27: 3–20.
Google Scholar | Crossref | Medline | ISI14. Menzies, D, Pai, M, Comstock, G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340–354.
Google Scholar | Crossref | Medline | ISI15. Pai, M, Zwerling, A, Menzies, D. Systematic review: T-cell–based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177–184.
Google Scholar | Crossref | Medline | ISI16. Seo, GH, Kim, MJ, Seo, S, et al. Cancer-specific incidence rates of tuberculosis: a 5-year nationwide population-based study in a country with an intermediate tuberculosis burden. Medicine (Baltim) 2016; 95: e4919.
Google Scholar | Crossref | Medline17. Chen, CY, Sheng, WH, Cheng, A, et al. Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies. BMC Infect Dis 2011; 11: 324.
Google Scholar | Crossref | Medline18. Liu, CJ, Hong, YC, Teng, CJ, et al. Risk and impact of tuberculosis in patients with chronic myeloid leukemia: a nationwide population-based study in Taiwan. Int J Cancer 2015; 136: 1881–1887.
Google Scholar | Crossref | Medline19. Anibarro, L, Pena, A. Tuberculosis in patients with haematological malignancies. Mediterr J Hematol Infect Dis 2014; 6: e2014026.
Google Scholar | Crossref | Medline20. Mazurek, GH, Jereb, J, Vernon, A, et al. Updated guidelines for using interferon-γ release assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Recomm Rep 2010; 59: 1–25.
Google Scholar | Medline21. European Centre for Disease Prevention and Control . Use of interferon-gamma release assays in support of TB diagnosis, https://www.ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/1103_GUI_IGRA.pdf (2011, accessed 1 July 2020)
Google Scholar22. Stop TB Department, Department of HIV/AIDS, World Health Organization . Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource constrained settings. WHO guidelines 2011, https://www.who.int/tb/publications/ICF_IPTguidelines/en/ (2011, accessed 1 July 2020)
Google Scholar23. Cellestis Limited . Quantiferon-TB Gold In-Tube (package insert). Victoria, Australia: QIAGEN Company, https://www.hshc.com.tw/data/files/201612/o_1b2vd080mcmg16nh1c3gg8v1hsd9.pdf (2013, accessed 1 July 2020).
Google Scholar24. Rosner, B . Fundamentals of biostatistics. 4th ed. Boston, MA: Duxbury Press, 1995.
Google Scholar25. Ferrara, G, Losi, M, Meacci, M, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005; 172: 631–635.
Google Scholar | Crossref | Medline26. Ferrara, G, Losi, M, D’Amico, R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367:1328–1334.
Google Scholar | Crossref | Medline | ISI27. Kobashi, Y, Sugiu, T, Mouri, K, et al. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 2009; 33: 812–815.
Google Scholar | Crossref | Medline28. Richeldi, L, Losi, M, D’Amico, R, et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 2009; 136: 198–204.
Google Scholar | Crossref | Medline | ISI29. Hangai, S, Yoshimi, A, Hosoi, A, et al. An indeterminate result of QuantiFERON-TB Gold In-Tube for miliary tuberculosis due to a high level of IFN-γ production. Int J Hematol 2014; 99: 523–526.
Google Scholar | Crossref | Medline30. Taiwan CDC Annual Report 2015, https://www.cdc.gov.tw/En/File/Get/rQ623mUguSI-o37ARHUJUQ (2015, accessed 3 May 2021).
Google Scholar31. Daver, N, McClain, K, Allen, CE, et al. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer 2017; 123: 3229–3240.
Google Scholar | Crossref | Medline32. Merli, P, Gentile, L, Quagliarella, F, et al. QuantiFERON-TB Gold can help clinicians in the diagnosis of haemophagocytic lymphohistiocytosis. Br J Haematol 2020; 191: e64–e67.
Google Scholar | Crossref | Medline33. Moon, SM, Lee, SO, Choi, SH, et al. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation. Transpl Infect Dis 2013; 15: 104–109.
Google Scholar | Crossref | Medline34. Goletti, D, Lee, MR, Wang, JY, et al. Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease. Respirology 2018; 23: 455–466.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif